pirodavir has been researched along with pradimicin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelnabi, R; Bator, CM; Camarasa, MJ; Delang, L; Gago, F; Hafenstein, S; Lee, H; Martí-Marí, O; Martínez-Gualda, B; Mirabelli, C; Neyts, J; Noppen, S; Quesada, E; San-Félix, A; Schols, D; Sun, L | 1 |
| Abdelnabi, R; Camarasa, MJ; Fernández-Barahona, I; Gago, F; Herranz, F; Martí-Marí, O; Martínez-Gualda, B; Mills, A; Neyts, J; Noppen, S; San-Félix, A; Schols, D | 1 |
2 other study(ies) available for pirodavir and pradimicin a
| Article | Year |
|---|---|
Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors.
Topics: Antiviral Agents; Capsid Proteins; CD4-Positive T-Lymphocytes; Enterovirus A, Human; HIV-1; HIV-2; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Protein Binding; Structure-Activity Relationship; Tryptophan; Virus Internalization; Virus Replication | 2020 |
Organotropic dendrons with high potency as HIV-1, HIV-2 and EV-A71 cell entry inhibitors.
Topics: Dendrimers; Enterovirus A, Human; Enterovirus Infections; HIV Fusion Inhibitors; HIV-1; HIV-2; Humans; Virus Internalization | 2022 |